19 June 2013
Keywords: mca, rejects, reintroduction, troglitazone, ukmca, uk, medicines
Article | 29 March 1999
The UK Medicines Control Agency has rejected an application by GlaxoWellcome to reintroduce Romozin (troglitazone) for the treatment of type
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 March 1999
29 March 1999
© 2013 thepharmaletter.com